Matrix metalloproteinase inhibitors reduce phorbol ester-induced cutaneous inflammation and hyperplasia

Archives of Dermatological Research

Volumn 289, Issue 3, 1997, Pages 138-144

  Holleran, Walter M ^a,b   Galardy, Richard E ^c,d   Gao, Wen Ni ^a,b   Levy, Daniel ^c   Tang, Peng Cho ^c   Elias, Peter M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Glycomed Inc   (United States)

^d NONE   (United States)

Author keywords

Collagenase; Cutaneous; Inflammation; Matrix metalloproteinase; Phorbol esters

Indexed keywords

COLLAGENASE; ILOMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PHORBOL DIBUTYRATE; PROTEINASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EAR; EPIDERMIS HYPERPLASIA; EXTRACELLULAR MATRIX; HUMAN EXPERIMENT; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SKIN INFLAMMATION; STRATUM CORNEUM; THICKNESS; TOPICAL DRUG ADMINISTRATION;

ANIMALS; DERMATITIS, CONTACT; DIPEPTIDES; EXTRACELLULAR MATRIX; HYPERPLASIA; METALLOENDOPEPTIDASES; MICE; MICE, INBRED HRS; PHORBOL 12,13-DIBUTYRATE; PROTEASE INHIBITORS; SKIN; TRYPTOPHAN;

EID: 0031034542     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050169     Document Type: Article

References (45)

1. Woesner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154
2. Twining SS (1994) Regulation of proteolytic activity in tissues. Crit Rev Biochem Mol Biol 29:315-383
3. Murphy G, Docherty AJ, Hembry RM, Reynolds JJ (1991) Metalloproteinases and tissue damage. Br J Rheumatol 30 [Suppl 1 ]:25-31
4. Eisen AZ (1969) Human skin collagenase: localization and distibution in normal human skin. J Invest Dermatol 52:449-453
5. Bauer EA, Stricklin GP, Jeffrey JJ, Eisen AZ (1975) Collagenase production by human skin fibroblasts. Biochem Biophys Res Commun 64:232-240
6. Wilhelm SM, Collier IE, Kronberger A, Eisen AZ, Mariner BL, Grant GA, Bauer EA, Goldberg GI. (1987) Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci USA 84:6725-6729
7. Woodley DT, Kalebec T, Banes AJ, Link W, Prunieras M, Liotta L (1986) Adult human keratinocytes migrating over non-viable dermal collagen produce collagenolytic enzymes that degrade type I and IV collagen. J Invest Dermatol 86:418-423
8. Petersen MJ, Woodley DT, Stricklin GP, O'Keefe EJ (1987) Production of procollagenase by cultured human keratinocytes J Biol Chem 262:835-840
9. Petersen MJ, Woodley DT, Stricklin GP, O'Keefe EJ (1989) Constitutive production of procollagenase and tissue inhibitor of metalloproteinases by human keratinocytes in culture. J Invest Dermatol 92:156-159
10. Girard MT, Matsubara M, Kublin C, Tessier MJ, Cintron C, Fini ME (1993) Stromal fibroblasts synthesize collagenase and stromelysin during long-term tissue remodeling. J Cell Sci 104:1001-1011
11. Fini ME, Girard MT (1990) Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest Ophthalmol Vis Sci 31:1779-1788
12. Dayer J-M, Derochemonteix B, Burrus B, Demczuk S, Dinarello C (1986) Human recombinant interleukin-1 stimulates collagenase and prostaglandin E-2 production by human synovial cells. J Clin Invest 77:645-648
13. Dayer J-M, Beutler B, Cerami A (1985) Cachectin tumor necrosis factor stimulates collagenase and prostaglandin E-2 production by human synovial cells and dermal fibroblasts. J Exp Med 162:2163-2168
14. Clark SD, Wilhelm SM, Stricklin GP, Welgus HG (1985) Coregulation of collagenase and collagenase inhibitor production by phorbol myristate acetate in human skin fibroblasts. Arch Biochem Biophys 241:36-44
15. Salo T, Turpeenniemi-Hujanen T, Tryggvason K (1985) Tumor-promoting phorbol esters and cell proliferation stimulate secretion of basement membrane (type IV) collagen-degrading metalloproteinase by human fibroblasts. J Biol Chem 260: 8526-8531
16. Moscatelli D, Jaffe E, Rifkin DB (1980) Tetradecanoyl phorbol acetate stimulates latent collagenase production by cultured human endothelial cells. Cell 20:343-351
17. Brinckerhoff CE, Gross RH, Nagase H, Sheldon L, Jackson RC, Harris ED Jr (1982) Increased level of translatable collagenase messenger ribonucleic acid in rabbit synovial fibroblasts treated with phorbol myristate acetate or crystals of monosodium urate monohydrate. Biochemistry 21:2674-2679
18. Bryce GF, Bogdan NJ, Brown CC (1988) Retinoic acids promote the repair of the dermal damage and the effacement of wrinkles in the UVB-irradiated hairless mouse. J Invest Dermatol 91:175-180
19. Bailly C, Dreze S, Asselineau D, Nusgens B, Lapiere CM, Darmon M (1990) Retinoic acid inhibits the production of collagenase by human epidermal keratinocytes. J Invest Dermatol 94:47-51
20. Fisher GJ, Datta SC, Talwar HS, Wang Z-Q, Varani J, Kang S, Voorhees JJ (1996) Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 379:335-339
21. Matrisian LM (1992) The matrix-degrading metalloproteinases. Bioessays 14:455-463
22. Saarialho-Kere UK, Kovacs SO, Pentland AP, Olerud JE, Welgus HG, Parks WC (1993) Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest 92:2858-2866
23. Galardy RE, Grobelny D, Foellmer HG, and Fernandez LA (1994) Inhibition of angiogenesis by the matrix metalloproteinase inhibitor GM 6001. Cancer Res 54:4715-4718
24. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA (1994) Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75:539-545
25. Grillo HC, Gross J (1967) Collagenolytic activity during mammalian wound repair. Dev Biol 15:300-317
26. Donoff RB (1970) Wound healing biochemical events and potential role of collagenase. J Oral Surg 28:356-363
27. Donoff RB, McLemman J, Grillo HC (1971) Preparation and properties of collagenases from epithelium and mesenchyme of healing mammalian wounds. Biochim Biophys Acta 227: 639-653
28. Glinski W, Pierozynska-Dubowska M. Glinska-Ferenz M, Jablonska S (1991) Decreased specific anti-elastase activity in the uninvolved skin of patients with psoriasis. Arch Dermatol Res 283:224-229
29. Feliciani C, Amerio P, D'orazi G, Vitullo P, Modesti A (1994) The 72 kDa and 92 kDa collagenase protein are expressed in psoriatic lesions (abstract). J Invest Dermatol 102:621a
30. Weckroth M, Vaheri A, Lauharanta J, Sorsa T, Konttinen YT (1996) Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J Invest Dermatol 106:1119-1124
31. Wysocki AB, Staiano-Coico L and Grinnell F (1993) Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101:64-68
32. Saarialho-Kere UK, Chang ES, Welgus HG. and Parks WC (1993) Expression of interstitial collagenase, 92-kDa gelatinase, and tissue inhibitor of metalloproteinases-1 in Granuloma Annulare and Necrobiosis Lipoidica Diabeticorum. J Invest Dermatol 100:335-342
33. Southgate KM, Davies M, Gooth RF, Newby AC (1992) Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem J 288:93-99
34. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K (1992) Growth-promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. FEBS Lett 298:29-32
35. Bertaux B, Hornebeck W, Eisen AZ, Dubertret L (1991) Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol 97:679-685
36. Schultz GS, Strelow S, Stern GA, Chegini N, Grant MB, Galardy RE, Grobelny D, Rowsey JJ, Stonecipher K, Parmley V, Khaw PT (1992) Treatment of alkali injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinase. Invest Ophthalmol Vis Sci 33:3325-3331
37. Galardy RE, Casabonne ME, Giese C, Gilbert JH, Lapierre F, Lopez H, Schaefer ME, Stack R, Sullivan M, Summers B, Tyrrell RTD, Wee J, Allen SD, Castellot JJ, Barletta JP, Schultz GS, Fernandez LA, Fisher S, Cui T-Y, Foellmer HG, Grobelny D, Holleran WM (1994) Low molecular weight inhibitors in corneal ulceration. Ann NY Acad Sci 73:315-323
38. Barszcz D, Zarebska Z, Glinska-Ferenz M, Jablonska S, Tigalonowa M, Glinski W (1988) Alpha 1-proteinase inhibitor in psoriasis: reduced activity in symptom-free patients and during flare. Arch Dermatological Res 280198-206
39. Nini G, Bianchi L, Angelini E, Corleto V, Gatti S, Carroxxo AM (1994) Evaluation of serine alpha 1-antitrypsin and poly-morphonucleur leukocyte elastase contents and their immunogenitic correlation in psoriasis. Acta Derm Venereol Suppl (Stockh) 186:143-145
40. Van de Kerkhof PCM, Kuppens LHCM, Van Vlijmen Y, Schalkwijk JS (1991) Distribution of skin-derived antileucoproteases (SKALP) in the marginal zone of the spreading psoriatic lesion. Br J Dermatol 124:10-20
41. Wiedow O, Wiese F, Christophers E (1995) Lesional elastase activity in psoriasis. Diagnostic and prognostic significance. Arch Dermatol Res 287:632-635
42. Mohler KH, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C. Greenstreet T, Weerwarna K, Kronhelm, SR, Peterson M, Gerhardt M, Kozlosky CJ, March CJ, Black RA (1994) Protection against a lethal dose of endotoxin by an inhibitor of tumor necrosis factor processing. Nature 370:218-220
43. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL et al. (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370: 555-557
44. Koob TJ, Jeffrey JJ, Eisen AZ, Bauer EA (1980) Hormonal interaction in mammalian collagenase regulation. Comparative studies in human skin and rat uterus. Biochim Biophys Acta 629:13-23
45. McGeehan GM, Becherer JD, Bast RC Jr, Boyer CM, Champion B, Connolly KM, Conway JG, Furdon P, Karp S, Kidao S et al. (1994) Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 370:558-561